Statin use and the risk of Parkinson's disease

被引：0
|
作者：
Etminan, M.
Carleton, B. C.
Samii, A.
机构：
[1] Vancouver Hosp, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada
[2] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada
[3] Univ Washington, Sch Med, Seattle, WA 98195 USA
[4] WA Parkinson Dis Res Educ & Clin Ctr PADRECC, Seattle, WA USA
来源：
MOVEMENT DISORDERS | 2007年 / 22卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
27
引用
收藏
页码：XII / XII
页数：1
相关论文
共 50 条
  • [41] Amphetamine Use and Risk of Parkinson's Disease in a Prospective Study
    Van Den Eeden, Stephen K.
    Tanner, Caroline M.
    Albers, Kathleen S.
    Shan, Jun
    Nelson, Lorene M.
    Christine, Chadwick W.
    Quesenberry, Charles P.
    NEUROLOGY, 2011, 76 (09) : A362 - A362
  • [42] Atypical antipsychotic use and mortality risk in Parkinson's disease
    Nguyen, Thanh Phuong Pham
    Thibault, Dylan
    Weintraub, Daniel
    Willis, Allison
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 282 - 282
  • [43] Parkinson's disease, levodopa-use and the risk of melanoma
    Vermeij, J-D.
    Winogrodzka, A.
    Trip, J.
    Weber, W. E. J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (08) : 551 - 553
  • [44] Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
    Chen, HL
    Jacobs, E
    Schwarzschild, MA
    McCullough, ML
    Calle, EE
    Thun, MJ
    Ascherio, A
    ANNALS OF NEUROLOGY, 2005, 58 (06) : 963 - 967
  • [45] Smokeless tobacco use and the risk of Parkinson's disease mortality
    O'Reilly, EJ
    McCullough, ML
    Chao, A
    Henley, SJ
    Calle, EE
    Henley, SJ
    Calle, EE
    Thun, MJ
    Ascherio, A
    MOVEMENT DISORDERS, 2005, 20 (10) : 1383 - 1384
  • [46] Stalin use and the risk of developing Parkinson's disease in Denmark
    Ritz, B.
    Wahner, A. D.
    Qian, L.
    Schernhammer, E.
    Olsen, J.
    Friis, S.
    MOVEMENT DISORDERS, 2009, 24 : S129 - S130
  • [47] Association Between Use of Furosemide and Risk of Parkinson's Disease
    Babar, Barkat Ali
    Tolppanen, Anna-Maija
    Hartikainen, Sirpa
    Tiihonen, Miia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 379 - 379
  • [48] Glitazone Use Associated With Reduced Risk of Parkinson's Disease
    Brakedal, Brage
    Flones, Irene
    Reiter, Simone F.
    Torkildsen, Oivind
    Dolle, Christian
    Assmus, Jorg
    Haugarvoll, Kristoffer
    Tzoulis, Charalampos
    MOVEMENT DISORDERS, 2017, 32 (11) : 1594 - 1599
  • [49] Use of antidepressants and the risk of Parkinson's disease: a prospective study
    Alonso, A.
    Garcia Rodriguez, L. A.
    Logroscino, G.
    Hernan, M. A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (06): : 671 - 674
  • [50] Calcium Channel Blocker Use and Risk of Parkinson's Disease
    Simon, Kelly Claire
    Gao, Xiang
    Chen, Honglei
    Schwarzschild, Michael A.
    Ascherio, Alberto
    MOVEMENT DISORDERS, 2010, 25 (12) : 1818 - 1822
12345